Thomas D. Martin

Thomas D. Martin

Auto-generated profile, based on publicly available information

Thomas D. Martin

MedImmune, LLC , One MedImmune Way, Gaithersburg, Maryland 20878, United States

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Cell Host & Microbe
Verified
Journal Article
Closed access
KLKyeongEun Lee
KyeongEun Lee
ZAZandrea Ambrose
Zandrea Ambrose
TMThomas D. Martin
Thomas D. Martin
IOIlker Oztop
Ilker Oztop
AMAlok Mulky
Alok Mulky
VKVineet N. KewalRamani
Vineet N. KewalRamani

12 March 2001 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABArman A. Bashirova
Arman A. Bashirova
TGTeunis B.H. Geijtenbeek
Teunis B.H. Geijtenbeek
GDGerard C.F. van Duijnhoven
Gerard C.F. van Duijnhoven
Sandra J. Van VlietSandra J. Van Vliet
Sandra J. Van Vliet
JEJeroen B.G. Eilering
Jeroen B.G. Eilering
MCMary Carrington
Mary Carrington
The discovery of dendritic cell (DC)-specific intercellular adhesion molecule (ICAM)-3–grabbing nonintegrin (DC-SIGN) as a DC-specific ICAM-3 binding receptor that enhances HIV-1 infection of T cells in trans has indicated a potentially important role for adhesion molecules in AIDS pathogenesis. A related molecule called DC-SIGNR exhibits 77% amino acid sequence identity with DC-SIGN. The DC-SIGN and DC-SIGNR genes map within a 30-kb region on chromosome 19p13.2-3. Their strong homology and close physical location indicate a recent duplication of the original gene. Messenger RNA and protein expression patterns demonstrate that the DC-SIGN–related molecule is highly expressed on liver sinusoidal cells and in the lymph node but not on DCs, in contrast to DC-SIGN. Therefore, we suggest that a more appropriate name for the DC-SIGN–related molecule is L-SIGN, liver/lymph node–specific ICAM-3–grabbing nonintegrin. We show that in the liver, L-SIGN is expressed by sinusoidal endothelial cells. Functional studies indicate that L-SIGN behaves similarly to DC-SIGN in that it has a high affinity for ICAM-3, captures HIV-1 through gp120 binding, and enhances HIV-1 infection of T cells in trans. We propose that L-SIGN may play an important role in the interaction between liver sinusoidal endothelium and trafficking lymphocytes, as well as function in the pathogenesis of HIV-1.

1 January 2004 in Virology
Verified
Journal Article
Closed access
LWLi Wu
Li Wu
TMThomas D. Martin
Thomas D. Martin
MCMary Carrington
Mary Carrington
VKVineet N. KewalRamani
Vineet N. KewalRamani

11 September 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MVMichael P. VanBrunt
Michael P. VanBrunt
KSKurt Shanebeck
Kurt Shanebeck
ZCZachary Caldwell
Zachary Caldwell
JJJeffrey Johnson
Jeffrey Johnson
PTPamela Thompson
Pamela Thompson
MMMarcello Marelli
Marcello Marelli

15 June 2002 in Journal of Virology
Verified
Journal Article
Open access
PDF file
LWLi Wu
Li Wu
TMThomas D. Martin
Thomas D. Martin
RVRosemay Vazeux
Rosemay Vazeux
DUDerya Unutmaz
Derya Unutmaz
VKVineet N. KewalRamani
Vineet N. KewalRamani
DC-SIGN, a type II membrane-spanning C-type lectin that is expressed on the surface of dendritic cells (DC), captures and promotes human and simian immunodeficiency virus (HIV and SIV) infection of CD4 + T cells in trans . To better understand the mechanism of DC-SIGN-mediated virus transmission, we generated and functionally evaluated a panel of seven monoclonal antibodies (MAbs) against DC-SIGN family molecules. Six of the MAbs reacted with myeloid-lineage DC, whereas one MAb preferentially bound DC-SIGNR/L-SIGN, a homolog of DC-SIGN. Characterization of hematopoietic cells also revealed that stimulation of monocytes with interleukin-4 (IL-4) or IL-13 was sufficient to induce expression of DC-SIGN. All DC-SIGN-reactive MAbs competed with intercellular adhesion molecule 3 (ICAM-3) for adhesion to DC-SIGN and blocked HIV-1 transmission to T cells that was mediated by THP-1 cells expressing DC-SIGN. Similar but less efficient MAb blocking of DC-mediated HIV-1 transmission was observed, indicating that HIV-1 transmission to target cells via DC may not be dependent solely on DC-SIGN. Attempts to neutralize DC-SIGN capture and transmission of HIV-1 with soluble ICAM-3 prophylaxis were limited in success, with a maximal inhibition of 60%. In addition, disrupting DC-SIGN/ICAM-3 interactions between cells with MAbs did not impair DC-SIGN-mediated HIV-1 transmission. Finally, forced expression of ICAM-3 on target cells did not increase their susceptibility to HIV-1 transmission mediated by DC-SIGN. While these findings do not discount the role of intercellular contact in facilitating HIV-1 transmission, our in vitro data indicate that DC-SIGN interactions with ICAM-3 do not promote DC-SIGN-mediated virus transmission.

1 September 2002 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
SFS. A. Fulton
S. A. Fulton
SRS. M. Reba
S. M. Reba
TMT. D. Martin
T. D. Martin
WBW. H. Boom
W. H. Boom
Although neutrophils have been identified as sources of inflammatory cytokines and chemokines, little is known about their immunologic function during mycobacterial infection in the lungs. In this study, we examined the growth ofMycobacterium bovisBCG in the lungs under experimental conditions that altered neutrophil recruitment to the lungs. Depletion and recruitment of neutrophils was associated with respective increases and decreases inM. bovisBCG growth. Thus, neutrophils may enhance mycobacteriocidal immunity in the lungs.